Direct-to-consumer information in Europe: The blurred margin between promotion and information

British Journal of Clinical Pharmacology

Volumn 66, Issue 5, 2008, Pages 626-628

  Velo, Giampaolo ^a   Moretti, Ugo ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Direct to consumer advertising (DTCA); Information; Promotion

Indexed keywords

CONSULTATION; CONSUMER HEALTH INFORMATION; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG MONITORING; DRUG USE; EUROPE; HEALTH CARE COST; HEALTH PROMOTION; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; SHORT SURVEY;

ADVERTISING AS TOPIC; CONSUMER HEALTH INFORMATION; EUROPEAN UNION; HEALTH PROMOTION; HUMANS; MASS MEDIA; PHARMACEUTICAL PREPARATIONS;

EID: 55149086575     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03283.x     Document Type: Short Survey

References (23)

1. Magrini N, Font M. Direct to consumer advertising of drugs in Europe. BMJ 2007 335 : 526 7.
2. The direct-to-consumer advertising genie. Lancet 2007 369 : 1.
3. Meek C. Europe reconsidering DTCA. CMAJ 2007 176 : 1405.
4. U.S. Government Accountability Office. Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising. GAO report Number GAO-07-54, 14 December 2006.
5. Gilbody S, Wilson P, Watt I. Benefits and harms of direct to consumer advertising: a systematic review. Qual Saf Health Care 2005 14 : 246 50.
6. Mintzes B. Direct-to-Consumer Advertising of Prescription Drugs in Canada: What are the Public Health Implications? Health Council of Canada, January 2006. Available at http://www.healthcouncilcanada.ca (last accessed: 30 June 2008).
7. Guthrie PUS. Congress to consider limits on DTCA. CMAJ 2007 176 : 1404.
8. Shuchman M. Drug risks and free speech - can Congress ban consumer drug ads? N Engl J Med 2007 356 : 2236 9.
9. Kmietowicz Z. New Zealand GPs call for end to direct to consumer advertising. BMJ 2003 326 (7402 1284.
10. WHO Pharmaceuticals Newsletter 2007 N. 6 page 8. Available at http://www.who.int/medicines/publications/newsletter/en (last accessed: 30 June 2008).
11. van Lierop T. Direct-to-consumer drug advertisement in Europe. Lancet 2007 369 : 1790.
12. European Commission. Draft report on current practice with regard to provision of information to patients on medicinal products. Summary of the public consultation responses. Available at http://ec.europa.eu/enterprise/ pharmaceuticals/pharmacos/docs/doc2007/2007_10/d-34327-summary-of-consultation- responses.pdf (last accessed: 30 June 2008).
13. European Commission. Public Consultation on Legal Proposal on Information to Patients. Available at http://ec.europa.eu/enterprise/pharmaceuticals/ pharmacos/docs/doc2008/2008_02/info_to_patients_consult_200802.pdf (last accessed 30 June 2008).
14. European Commission. Outcome of the Public Consultation on the Key Elements of a Legal Proposal on Information to Patients. Available at http://ec.europa.eu/enterprise/pharmaceuticals/patients/patients_key.htm (last accessed 30 June 2008).
15. Richards T. Purely medicinal? BMJ 2008 336 (7646 693.
16. Medawar C. Direct to consumer advertising: a cynical consultation exercise? BMJ 2008 336 : 787.
17. Direct-to-consumer advertising under a different name. Lancet 2008 371 : 1972.
18. European Commission. European Commission Draft Report on Current Practice with Regard to Provision of Information to Patients on Medicinal Products. 19 April 2007. Available at http://ec.europa.eu/enterprise/pharmaceuticals/ pharmacos/docs/doc2007/2007_04/draft_infopatients2007_04.pdf (last accessed 30 June 2008).
19. Interacting Advertising Bureau. Press release, 15 May 2008. Available at http://www.iab.net/about_the_iab/recent_press_releases/press_release_archive/ press_release/299609 (last accessed 30 June 2008).
20. Search Engine Marketing Professional Organization (SEMPO). Press release, 17 March 2008. Available at http://www.sempo.org/news/releases/03-17-08 (last accessed 30 June 2008).
21. Davis JJ, Cross E, Crowley J. Pharmaceutical websites and the communication of risk information. J Health Commun 2007 12 : 29 39.
22. Read J. Schizophrenia, drug companies and the internet. Soc Sci Med 2008 66 : 99 109.
23. Charvet-Berard AI, Chopard P, Perneger TV. Measuring quality of patient information documents with an expanded EQIP scale. Patient Educ Couns 2008 70 : 407 11.